PLGA Based Drug Carrier and Pharmaceutical Applications

Poly(lactic-co-glycolic acid) (PLGA) is one of the most successful polymers used for producing therapeutic devices, such as drug carriers (DC). PLGA is one of the few polymers that the Food and Drug Administration (FDA) has approved for human administration due to its biocompatibility and biodegrada...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (328 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545575204498
ctrlnum (CKB)5400000000040814
(oapen)https://directory.doabooks.org/handle/20.500.12854/68416
(EXLCZ)995400000000040814
collection bib_alma
record_format marc
spelling Pereira, Maria Carmo edt
PLGA Based Drug Carrier and Pharmaceutical Applications
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
1 electronic resource (328 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Poly(lactic-co-glycolic acid) (PLGA) is one of the most successful polymers used for producing therapeutic devices, such as drug carriers (DC). PLGA is one of the few polymers that the Food and Drug Administration (FDA) has approved for human administration due to its biocompatibility and biodegradability. In recent years, DC produced with PLGA has gained enormous attention for its versatility in transporting different type of drugs, e.g., hydrophilic or hydrophobic small molecules, or macromolecules with a controlled drug release without modifying the physiochemical properties of the drugs. These drug delivery systems have the possibility/potential to modify their surface properties with functional groups, peptides, or other coatings to improve the interactions with biological materials. Furthermore, they present the possibility to be conjugated with specific target molecules to reach specific tissues or cells. They are also used for different therapeutic applications, such as in vaccinations, cancer treatment, neurological disorder treatment, and as anti-inflammatory agents. This book aims to focus on the recent progress of PLGA as a drug carrier and their new pharmaceutical applications.
English
Medicine bicssc
PLGA
nanoscaled drug delivery
LED
cancer
serum stability
reactive oxygen species
cellular uptake
terahertz spectroscopy
microspheres
drug delivery
formulation development
molecular mobility
vitamin E
tocopherol
PLA
core-shell nanoparticles
controlled drug release
BMP-2
PLGA nanoparticles
Pluronic F68
oxaliplatin
hydrogel
intra-abdominal anti-adhesion barrier
colorectal cancer
experimental design
fractional factorial design
O6-methylguanine DNA methyltransferase (MGMT) protein
glioblastoma multiforme
smart nanocarriers
folic acid
verteporfin
cisplatin
SKOV-3 cells
CHO-K1 cells
electroporation
theranostic cargo
double emulsion approach
NSAIDs
polymeric film
topical drug delivery
trolamine salicylate
triamcinolone acetonide
microcrystal
PLGA microsphere
local delivery
spray-drying technique
intra-articular injection
joint retention
systemic exposure
gadolinium
drug release
polymeric nanocarrier
sorafenib
theranostic nanoparticles
PLGA-PEG
nanoparticles
platelet
activation
aggregation
binding
uptake
tissue engineering
Huntington's disease
siRNA
microcarriers
mesenchymal stromal cells
drug delivery systems
microfluidics
microparticles
BMP-2-microspheres
hydrogel system
17-βestradiol release
bone regeneration
osteoporosis
poly-lactide-co-glycolide
polylactic acid
alginate
ophthalmic drug delivery
dexamethasone
PLGA-NPs
nanomedicine
gastrointestinal tract
paclitaxel
in vivo imaging
controlled release
risperidone
microcapsules
oleogels
electron microscopy
three-dimensional X-ray imaging
nano-CT
biodegradable polymers
hydroxy-stearic acid
PLGA nanocapsules
magnetic resonance imaging
photoluminescence
magnetic targeting
multimodal imaging
theranostics
silicon
microsphere
3-0365-0220-3
3-0365-0221-1
Loureiro, Joana edt
Pereira, Maria Carmo oth
Loureiro, Joana oth
language English
format eBook
author2 Loureiro, Joana
Pereira, Maria Carmo
Loureiro, Joana
author_facet Loureiro, Joana
Pereira, Maria Carmo
Loureiro, Joana
author2_variant m c p mc mcp
j l jl
author2_role HerausgeberIn
Sonstige
Sonstige
title PLGA Based Drug Carrier and Pharmaceutical Applications
spellingShingle PLGA Based Drug Carrier and Pharmaceutical Applications
title_full PLGA Based Drug Carrier and Pharmaceutical Applications
title_fullStr PLGA Based Drug Carrier and Pharmaceutical Applications
title_full_unstemmed PLGA Based Drug Carrier and Pharmaceutical Applications
title_auth PLGA Based Drug Carrier and Pharmaceutical Applications
title_new PLGA Based Drug Carrier and Pharmaceutical Applications
title_sort plga based drug carrier and pharmaceutical applications
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2021
physical 1 electronic resource (328 p.)
isbn 3-0365-0220-3
3-0365-0221-1
illustrated Not Illustrated
work_keys_str_mv AT pereiramariacarmo plgabaseddrugcarrierandpharmaceuticalapplications
AT loureirojoana plgabaseddrugcarrierandpharmaceuticalapplications
status_str n
ids_txt_mv (CKB)5400000000040814
(oapen)https://directory.doabooks.org/handle/20.500.12854/68416
(EXLCZ)995400000000040814
carrierType_str_mv cr
is_hierarchy_title PLGA Based Drug Carrier and Pharmaceutical Applications
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
_version_ 1787548474730872832
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05509nam-a2201525z--4500</leader><controlfield tag="001">993545575204498</controlfield><controlfield tag="005">20231214133254.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000040814</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68416</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000040814</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pereira, Maria Carmo</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">PLGA Based Drug Carrier and Pharmaceutical Applications</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (328 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Poly(lactic-co-glycolic acid) (PLGA) is one of the most successful polymers used for producing therapeutic devices, such as drug carriers (DC). PLGA is one of the few polymers that the Food and Drug Administration (FDA) has approved for human administration due to its biocompatibility and biodegradability. In recent years, DC produced with PLGA has gained enormous attention for its versatility in transporting different type of drugs, e.g., hydrophilic or hydrophobic small molecules, or macromolecules with a controlled drug release without modifying the physiochemical properties of the drugs. These drug delivery systems have the possibility/potential to modify their surface properties with functional groups, peptides, or other coatings to improve the interactions with biological materials. Furthermore, they present the possibility to be conjugated with specific target molecules to reach specific tissues or cells. They are also used for different therapeutic applications, such as in vaccinations, cancer treatment, neurological disorder treatment, and as anti-inflammatory agents. This book aims to focus on the recent progress of PLGA as a drug carrier and their new pharmaceutical applications.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PLGA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanoscaled drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LED</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">serum stability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">reactive oxygen species</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cellular uptake</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">terahertz spectroscopy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microspheres</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">formulation development</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular mobility</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vitamin E</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tocopherol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PLA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">core-shell nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">controlled drug release</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BMP-2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PLGA nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pluronic F68</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oxaliplatin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intra-abdominal anti-adhesion barrier</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colorectal cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">experimental design</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fractional factorial design</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">O6-methylguanine DNA methyltransferase (MGMT) protein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glioblastoma multiforme</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">smart nanocarriers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">folic acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">verteporfin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cisplatin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SKOV-3 cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CHO-K1 cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">electroporation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">theranostic cargo</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">double emulsion approach</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NSAIDs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polymeric film</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">topical drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">trolamine salicylate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">triamcinolone acetonide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microcrystal</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PLGA microsphere</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">local delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">spray-drying technique</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intra-articular injection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">joint retention</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">systemic exposure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gadolinium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug release</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polymeric nanocarrier</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sorafenib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">theranostic nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PLGA-PEG</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">platelet</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">activation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aggregation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">binding</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">uptake</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tissue engineering</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Huntington's disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">siRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microcarriers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mesenchymal stromal cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug delivery systems</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microfluidics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BMP-2-microspheres</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogel system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">17-βestradiol release</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bone regeneration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">osteoporosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">poly-lactide-co-glycolide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polylactic acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">alginate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ophthalmic drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dexamethasone</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PLGA-NPs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanomedicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gastrointestinal tract</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">paclitaxel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vivo imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">controlled release</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">risperidone</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microcapsules</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oleogels</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">electron microscopy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">three-dimensional X-ray imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nano-CT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biodegradable polymers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydroxy-stearic acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PLGA nanocapsules</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">magnetic resonance imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">photoluminescence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">magnetic targeting</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multimodal imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">theranostics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">silicon</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microsphere</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-0220-3</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-0221-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Loureiro, Joana</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pereira, Maria Carmo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Loureiro, Joana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:48:47 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337985080004498&amp;Force_direct=true</subfield><subfield code="Z">5337985080004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337985080004498</subfield></datafield></record></collection>